⌘K

Home/Filings/4/0001144204-18-020555

4//SEC Filing

CAPITELLI SARA B 4

Accession 0001144204-18-020555

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 6:03 PM ET

Size

10.0 KB

Accession

0001144204-18-020555

Insider Transaction Report

Form 4

Period: 2018-04-12

CASI Pharmaceuticals, Inc.CASI

CAPITELLI SARA B

VP, Finance and PAO

Transactions

Exercise/Conversion
Common Stock
2018-04-12$0.88/sh+26,978$23,741→ 26,978 total
Tax Payment
Common Stock
2018-04-12$6.62/sh−8,200$54,284→ 18,778 total
Disposition to Issuer
Common Stock
2018-04-12$6.62/sh−18,778$124,310→ 0 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-04-12−26,978→ 0 total
Exercise: $0.88Exp: 2026-03-02→ Common Stock (26,978 underlying)

Footnotes (1)

[F1]These stock options are the vested portion of stock options that were granted on March 2, 2016 which vested or will vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.

Documents

1 file

4
tv491089_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001509032

Filing Metadata

Form type: 4
Filed: Apr 12, 8:00 PM ET
Accepted: Apr 13, 6:03 PM ET
Size: 10.0 KB

View on SEC.gov